Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04748302 · ClinicalTrials.gov registry record
Impaired Glucose Tolerance and Cognition in MS
A clinical trial, sponsored by University of Virginia.
- Terminated
- Registry status
- 7
- Enrollment target
NCT04748302 is a clinical trial that was terminated before completion, run by University of Virginia. The registered enrollment target is 7 participants.
The verdict
NCT04748302 was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a pilot study to compare cognitive performance in two groups of subjects with multiple sclerosis; those with normal glucose tolerance and those with impaired glucose tolerance. The study consists of a 2 hour oral glucose tolerance test, patient reported outcomes, a series of cognitive functioning tests, and outpatient physical assessment using a pedometer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2020-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04748302
The ClinicalTrials.gov registry entry for NCT04748302 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04748302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04748302 about?
NCT04748302 is a clinical study titled "Impaired Glucose Tolerance and Cognition in MS". This is a pilot study to compare cognitive performance in two groups of subjects with multiple sclerosis; those with normal glucose tolerance and those with impaired glucose tolerance. The study consists of a 2 hour oral glucose tolerance test, patient reported outcomes, a series of cognitive functi...
What is the current status of trial NCT04748302?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2020-01-06. Estimated completion is 2020-04-01.
Who is sponsoring clinical trial NCT04748302?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.